Stomach cancer rarely gets its own national moment. It sits in the background of November's observances, overshadowed by louder campaigns. That quiet may be part of the problem. When a disease is not on a person's radar, the conversation that could change the outcome depends on whether a clinician thinks to start it.

MB's assignment is to be precise about that conversation. It is not a story that says everyone needs an endoscopy. It is a story about risk assessment: who is at higher risk, who should be asked about it, and who is responsible for making sure the next conversation happens.

What is known about risk

The National Cancer Institute reports that stomach cancer occurs more frequently among Black, Hispanic, Asian or Pacific Islander, and American Indian or Alaska Native populations than among White populations in the United States. Chronic Helicobacter pylori infection is a major risk factor, and treating the infection reduces risk for certain stomach cancers. NCI also states that there is no standard routine screening test for the general U.S. population.[1]

That last sentence is easy to skip, and it is the one that keeps the story honest. For people at average risk, NCI says there are no standard or routine screening tests. The conversation MB is asking about is not routine screening. It is the narrower question of whether people with specific risk factors are identified and offered a discussion.

What gastroenterologists now advise for higher-risk groups

In December 2024, the American Gastroenterological Association published a Clinical Practice Update on screening and surveillance for people at increased risk of gastric cancer in the United States. It describes gastric cancer as a leading cause of preventable cancer and mortality in certain U.S. populations, and states that the most impactful way to reduce mortality is primary prevention, meaning H. pylori eradication, and secondary prevention, meaning endoscopic screening and surveillance of precancerous conditions. Its first piece of best-practice advice identifies groups who should be considered for screening: first-generation immigrants from high-incidence regions and possibly other non-White racial and ethnic groups, people with a family history of gastric cancer in a first-degree relative, and people with certain hereditary conditions.[2]

Two other points in the update matter for an accountability story. It advises that opportunistic screening for H. pylori infection should be considered for people at increased risk, and that adult household members of someone who tests positive should also be considered for testing. And it acknowledges a gap on the clinician side: findings such as intestinal metaplasia and dysplasia are often missed when endoscopists are unfamiliar with their visual features, and the authors say there is an unmet need for training in the United States.[2]

The update carries a caution too. Its statements come from literature review and expert opinion and do not carry formal ratings of evidence quality, and the authors say optimal intervals for repeat screening are not well defined.[2] A separate 2025 review from a U.S. perspective makes a similar point: several guidelines recommend H. pylori screening in high-risk groups, but specific guidance on how to implement population screening, and its cost-effectiveness, is lacking.[3]

The guidance says who might be at higher risk. It does not say who has the job of asking.

Where the conversation can fall through

Put those pieces together and a pattern of questions emerges, none of which MB can answer yet.

Link in the chainThe question
Recognizing riskIs a patient's family history, country of birth, or H. pylori history captured in a way a clinician sees during a ten-minute visit?
Raising the topicWhose job is it to bring up stomach cancer risk with a patient who has no symptoms?
Testing for H. pyloriIs testing offered, covered, and followed by treatment and confirmation that the infection cleared?
Referral for evaluationIf a clinician recommends endoscopy, how long does the referral take, and who tracks it?
Community reachDo community health workers and trusted organizations have accurate, non-alarming material to share?

The last row matters for equity. If higher-risk communities are also the communities less likely to have a long-standing primary care relationship, the conversation may depend on the people who already work in those communities, such as health workers and navigators. They deserve both attention and resources.

What this story must not say

  • That any group should be screened. MB reports who recommends what, with attribution.
  • That higher incidence has a single cause. The sources describe risk factors, and what is unknown should be said plainly.
  • That any named institution fails to discuss risk. That requires reporting and a response.
What The Evidence Can And Cannot Tell Us

It can tell us that a professional society now identifies higher-risk groups who should be considered for screening and that H. pylori testing is part of prevention.

It cannot tell us how often clinicians actually raise the topic, or how long the path to an endoscopy takes in any community.

It cannot tell a reader whether to be screened. That is a clinical decision.

If a clinician asked about your family's history of stomach cancer, or never did, tell us what happened.

Sources